BVS
Income statement / Annual
Last year (2025), Bioventus Inc's total revenue was $568.09 M,
a decrease of 0.91% from the previous year.
In 2025, Bioventus Inc's net income was $22.73 M.
See Bioventus Inc,s key income statements, including revenue, expenses, profit, and income.
| Period |
FY-2025
|
FY-2024
|
FY-2023
|
FY-2022
|
FY-2021
|
FY-2020
|
FY-2019
|
FY-2018
|
FY-2017
|
FY-2016
|
| Period Ended |
12/31/2025 |
12/31/2024 |
12/31/2023 |
12/31/2022 |
12/31/2021 |
12/31/2020 |
12/31/2019 |
12/31/2018 |
12/31/2017 |
12/31/2016 |
| Operating Revenue |
$568.09 M |
$573.28 M |
$512.35 M |
$512.12 M |
$430.90 M |
$321.16 M |
$340.14 M |
$319.18 M |
$292.06 M |
$274.50 M |
| Cost of Revenue |
$185.66 M
|
$185.05 M
|
$184.15 M
|
$181.04 M
|
$128.19 M
|
$87.64 M
|
$90.94 M
|
$84.17 M
|
$92.10 M
|
$91.39 M
|
| Gross Profit |
$382.43 M
|
$388.23 M
|
$328.19 M
|
$331.08 M
|
$302.71 M
|
$233.52 M
|
$249.21 M
|
$235.01 M
|
$199.96 M
|
$183.11 M
|
| Gross Profit Ratio |
0.67
|
0.68
|
0.64
|
0.65
|
0.7
|
0.73
|
0.73
|
0.74
|
0.68
|
0.67
|
| Research and Development Expenses |
$12.11 M
|
$13.64 M
|
$13.45 M
|
$23.85 M
|
$19.04 M
|
$11.20 M
|
$11.06 M
|
$8.10 M
|
$8.10 M
|
$7.90 M
|
| General & Administrative Expenses |
$0.00
|
$322.67 M
|
$300.03 M
|
$326.93 M
|
$0.00
|
$0.00
|
$196.12 M
|
$0.00
|
$0.00
|
$0.00
|
| Selling & Marketing Expenses |
$0.00
|
$4.42 M
|
$3.85 M
|
$5.20 M
|
$0.00
|
$0.00
|
$2.35 M
|
$0.00
|
$0.00
|
$0.00
|
| Selling, General & Administrative Expenses |
$314.03 M
|
$327.09 M
|
$303.88 M
|
$332.13 M
|
$254.25 M
|
$193.08 M
|
$198.48 M
|
$191.67 M
|
$164.84 M
|
$160.32 M
|
| Other Expenses |
-$2.26 M
|
$59.47 M
|
$92.59 M
|
$142.33 M
|
$17.35 M
|
$8.00 M
|
$8.48 M
|
$9.74 M
|
$0.00
|
$0.00
|
| Operating Expenses |
$323.88 M
|
$400.21 M
|
$409.92 M
|
$498.31 M
|
$290.65 M
|
$212.28 M
|
$218.01 M
|
$209.51 M
|
$172.94 M
|
$168.22 M
|
| Cost And Expenses |
$509.54 M
|
$585.26 M
|
$594.07 M
|
$679.35 M
|
$418.84 M
|
$299.92 M
|
$308.95 M
|
$293.67 M
|
$265.04 M
|
$259.61 M
|
| Interest Income |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Interest Expense |
$26.49 M
|
$38.79 M
|
$40.68 M
|
$12.02 M
|
$1.11 M
|
$9.75 M
|
$21.58 M
|
$19.17 M
|
$18.90 M
|
$15.94 M
|
| Depreciation & Amortization |
$47.01 M
|
$49.56 M
|
$57.37 M
|
$55.40 M
|
$34.88 M
|
$28.64 M
|
$30.32 M
|
$29.24 M
|
$32.29 M
|
$33.76 M
|
| EBITDA |
$105.56 M |
$39.22 M |
-$23.07 M |
-$121.61 M |
$45.48 M |
$54.31 M |
$61.58 M |
$54.52 M |
$59.85 M |
$44.05 M |
| EBITDA Ratio |
0.19
|
0.07
|
-0.05
|
-0.24
|
0.11
|
0.17
|
0.18
|
0.17
|
0.2
|
0.16
|
| Operating Income Ratio |
0.1
|
-0.02
|
-0.16
|
-0.33
|
0.03
|
0.07
|
0.09
|
0.08
|
0.09
|
0.05
|
| Total Other Income/Expenses Net |
-$32.84 M
|
-$37.15 M
|
-$39.39 M
|
-$21.79 M
|
-$2.57 M
|
-$5.32 M
|
-$21.50 M
|
-$19.40 M
|
-$18.37 M
|
-$20.54 M
|
| Income Before Tax |
$25.71 M
|
-$49.13 M
|
-$121.11 M
|
-$189.03 M
|
$9.49 M
|
$15.91 M
|
$9.69 M
|
$6.11 M
|
$8.66 M
|
-$5.65 M
|
| Income Before Tax Ratio |
0.05
|
-0.09
|
-0.24
|
-0.37
|
0.02
|
0.05
|
0.03
|
0.02
|
0.03
|
-0.02
|
| Income Tax Expense |
-$1.57 M
|
-$5.29 M
|
$85.00 K
|
-$44.37 M
|
-$1.97 M
|
$1.19 M
|
$1.58 M
|
$1.66 M
|
-$785.00 K
|
$1.09 M
|
| Net Income |
$22.73 M
|
-$33.54 M
|
-$156.23 M
|
-$158.70 M
|
$19.38 M
|
$16.41 M
|
$6.85 M
|
-$12.21 M
|
-$1.64 M
|
-$17.95 M
|
| Net Income Ratio |
0.04
|
-0.06
|
-0.3
|
-0.31
|
0.04
|
0.05
|
0.02
|
-0.04
|
-0.01
|
-0.07
|
| EPS |
0.34 |
-0.52 |
-2.49 |
-2.59 |
-0.15 |
0.44 |
0.12 |
-0.22 |
-0.0288 |
-0.32 |
| EPS Diluted |
0.33 |
-0.52 |
-2.49 |
-2.59 |
-0.15 |
0.44 |
0.12 |
-0.22 |
-0.0288 |
-0.32 |
| Weighted Average Shares Out |
$66.62 M
|
$65.36 M
|
$62.65 M
|
$61.39 M
|
$45.47 M
|
$37.70 M
|
$56.83 M
|
$56.83 M
|
$56.83 M
|
$56.83 M
|
| Weighted Average Shares Out Diluted |
$68.91 M
|
$65.36 M
|
$62.65 M
|
$61.39 M
|
$45.47 M
|
$37.70 M
|
$56.83 M
|
$56.83 M
|
$56.83 M
|
$56.83 M
|
| Link |
|
|
|
|
|
|
|
|
|
|
